Anika Therapeutics, Inc. (ANIK)

NASDAQ: ANIK · Real-Time Price · USD

21.78

+0.44 (2.06%)

At close: Aug 21, 2026, 4:00 PM EDT

21.78

0.00 (0.00%)

After-hours: Aug 21, 2026, 4:10 PM EDT

Anika Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	120.65	112.82	119.91	120.79	113.83	147.79
Revenue Growth	5.33%	-5.91%	-0.73%	6.12%	-22.98%	13.29%
Cost of Revenue	45.65	49.01	43.3	38.26	40.61	58.39
Gross Profit	75	63.81	76.6	82.53	73.22	89.41
Selling, General & Admin	50.15	49.09	55.56	59.93	51.23	74.1
Research & Development	27.45	25.77	25.54	21.76	18.32	27.33
Operating Expenses	77.6	74.86	81.1	81.69	69.55	101.42
Operating Income	-2.59	-11.05	-4.5	0.84	3.67	-12.02
Interest Expense	-	-	-	-	-	-0.19
Interest & Investment Income	2.21	1.74	2.34	2.31	0.65	-
EBT Excluding Unusual Items	-0.39	-9.31	-2.16	3.16	4.32	-12.2
Merger & Restructuring Charges	-2.36	-	-0.61	-	-	-6.47
Other Unusual Items	-0.17	-	-	-	-	21.1
Pretax Income	-2.91	-9.31	-2.76	3.16	4.32	2.43
Income Tax Expense	0.21	0.67	6.06	6.6	2.12	-1.71
Earnings From Continuing Operations	-3.12	-9.98	-8.83	-3.44	2.2	4.13
Earnings From Discontinued Operations	-0.66	-0.9	-47.56	-79.23	-17.06	-
Net Income	-3.78	-10.88	-56.39	-82.67	-14.86	4.13
Net Income to Common	-3.78	-10.88	-56.39	-82.67	-14.86	4.13
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	14	14	15	15	15	14
Shares Outstanding (Diluted)	14	14	15	15	15	15
Shares Change	-4.23%	-2.60%	0.44%	0.65%	-0.50%	2.90%
EPS (Basic)	-0.27	-0.76	-3.83	-5.64	-1.02	0.29
EPS (Diluted)	-0.28	-0.76	-3.83	-5.64	-1.02	0.28
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	0.56	4.36	-2.33	-7.22	-3.08	3.25
Free Cash Flow Per Share	0.04	0.30	-0.16	-0.49	-0.21	0.22
Gross Margin	62.17%	56.56%	63.89%	68.33%	64.33%	60.49%
Operating Margin	-2.15%	-9.79%	-3.75%	0.70%	3.22%	-8.13%
Profit Margin	-3.14%	-9.64%	-47.02%	-68.44%	-13.05%	2.80%
Free Cash Flow Margin	0.47%	3.87%	-1.94%	-5.97%	-2.70%	2.20%
EBITDA	3.04	-5.47	1.19	6.35	9.16	2.3
EBITDA Margin	2.52%	-4.85%	1.00%	5.26%	8.04%	1.56%
D&A For EBITDA	5.63	5.58	5.69	5.51	5.49	14.32
EBIT	-2.59	-11.05	-4.5	0.84	3.67	-12.02
EBIT Margin	-2.15%	-9.79%	-3.75%	0.70%	3.22%	-8.13%
Effective Tax Rate	-	-	-	208.97%	49.12%	-

SEC Filings: 10-K · 10-Q